Fda
-
The PrimerThe Complex Legal Landscape of Abortion Laws After Dobbs
Jul 9, 2026
Explore how abortion laws have evolved post-Dobbs decision, creating a patchwork of state policies and ongoing legal battles shaping access nationwide.
-
Courts & LawFDA Commissioner Marty Makary Resigns Amid Pro-Life Pressure on Abortion Drug Policies
May 13, 2026
FDA Commissioner Marty Makary resigned following pro-life criticism, raising expectations for changes in abortion drug regulations under Trump.
-
Courts & Law5th Circuit Court Pauses FDA's Mail-Order Abortion Drug Permissions
May 6, 2026
The 5th Circuit Court has paused FDA's mail-order abortion drug permissions amid concerns over safety and financial interests of drug manufacturers.
-
Courts & Law5th Circuit Court Blocks FDA Policy on Mail-Order Abortion Drugs
May 2, 2026
The 5th Circuit Court temporarily halts a Biden-era FDA policy allowing mail-order abortion drugs, citing safety concerns and legal challenges from Louisiana.
-
Courts & LawSenate Republicans Investigate Mifepristone Manufacturers Over Safety Concerns
Mar 26, 2026
Senate Republicans are probing mifepristone manufacturers for alleged safety violations and mail-order abortion practices, raising concerns about compliance.
-
Courts & LawTrump DOJ Seeks Pause on Abortion Pill Lawsuit Amid Safety Review
Mar 16, 2026
The Trump administration's DOJ is calling for a pause on lawsuits challenging the FDA's approval of mifepristone, citing ongoing safety reviews.
-
HealthHawley Introduces Bill to Ban Mifepristone, Citing Health Risks
Mar 11, 2026
Sen. Josh Hawley has introduced legislation to ban mifepristone, citing health risks to women and unborn children, amid calls for stricter regulations.
-
HealthFDA Commissioner Confirms Review of Abortion Pill Mifepristone Underway
Dec 10, 2025
FDA Commissioner Marty Makary announced a review of mifepristone will be released once completed, amid rising concerns over its safety and accessibility.
-
OpinionFDA Acknowledges Covid Vaccine-Related Deaths, Impacting Gen Z's Trust in Government
Dec 5, 2025
The FDA's admission of Covid vaccine-related deaths has intensified skepticism among Gen Z towards government institutions and health mandates.
-
EducationThe Government Gives Too Much Authority To Leftist Academics
Nov 7, 2025
The recent actions of the International Association of Genocide Scholars, which accused Israel of committing genocide in Gaza, have raised concerns about the.
-
Courts & LawWoman Coerced Into Abortion Sues FDA Over Mail-Order Drug Access
Oct 30, 2025
Rosalie Markezich, a Louisiana resident, is suing the U.S. Food and Drug Administration (FDA) for allegedly enabling a mail-order abortion scheme that she.
-
Courts & LawInaction On Abortion Pill Puts Women At Risk Of Harm, Abuse
Oct 28, 2025
The Biden administration's decision to allow mail-order prescriptions for mifepristone, a medication used for abortion, has raised concerns about the safety of.
-
Courts & Law51 GOP Senators Urge HHS, FDA to Restrict Abortion Drug
Oct 10, 2025
Fifty-one Republican senators have called on the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) to take immediate.
-
Courts & LawLouisiana Demands FDA End ‘Illegal’ Mail-Order Abortion Pills
Oct 9, 2025
Louisiana Attorney General Liz Murrill and a Louisiana woman who survived abortion pill poisoning have filed a lawsuit against the U.S. Food and Drug.
-
Courts & LawAmid Review Of Deadly Abortion Drug, FDA Greenlights Copycat
Oct 2, 2025
The U.S. Food and Drug Administration (FDA) has approved a generic version of mifepristone, a medication widely used for abortions, manufactured by Evita.
-
HealthConcerns Over Acetaminophen Use During Pregnancy Spark Debate
Sep 29, 2025
Recent discussions surrounding the safety of acetaminophen, commonly known as Tylenol, during pregnancy have intensified, particularly following remarks made by.
-
HealthFDA Reviewing Mifepristone Safety Data, Says HHS Secretary Kennedy
Sep 4, 2025
Health and Human Services Secretary Robert F. Kennedy Jr. confirmed on Thursday that the U.S. Food and Drug Administration (FDA) is actively reviewing safety.